RXO Inc (RXO) is now in the Overvalued zone, suggesting that its current forward PE ratio of 414.19 is considered Overvalued compared with the five-year average of 85.45. The fair price of RXO Inc (RXO) is between 0.29 to 5.63 according to relative valuation method. Compared to the current price of 16.27 USD , RXO Inc By Overvalued By 188.85%.

Relative Value

Fair Zone

0.29-5.63

Current Price：16.27

188.85%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is RXO Inc (RXO) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

RXO Inc (RXO) has a current Price-to-Book (P/B) ratio of 1.33. Compared to its 3-year average P/B ratio of 3.35, the current P/B ratio is approximately -60.14% higher. Relative to its 5-year average P/B ratio of 3.28, the current P/B ratio is about -59.34% higher. RXO Inc (RXO) has a Forward Free Cash Flow (FCF) yield of approximately -0.85%. Compared to its 3-year average FCF yield of 1.23%, the current FCF yield is approximately -169.41% lower. Relative to its 5-year average FCF yield of 2.34%, the current FCF yield is about -136.54% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for RXO competitors is 4.03, providing a benchmark for relative valuation. RXO Inc Corp (RXO.N) exhibits a P/S ratio of --, which is -100% above the industry average. Given its robust revenue growth of -11.88%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of RXO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of RXO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is RXO currently overvalued or undervalued?

What is RXO Inc (RXO) fair value?

RXO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of RXO Inc (RXO) is between 0.29 to 5.63 according to relative valuation method.

How does RXO's valuation metrics compare to the industry average?

The average P/S ratio for RXO's competitors is 4.03, providing a benchmark for relative valuation. RXO Inc Corp (RXO) exhibits a P/S ratio of --, which is -100.00% above the industry average. Given its robust revenue growth of -11.88%, this premium appears unsustainable.

What is the current P/B ratio for RXO Inc (RXO) as of Mar 03 2026?

As of Mar 03 2026, RXO Inc (RXO) has a P/B ratio of 1.33. This indicates that the market values RXO at 1.33 times its book value.

What is the current FCF Yield for RXO Inc (RXO) as of Mar 03 2026?

As of Mar 03 2026, RXO Inc (RXO) has a FCF Yield of -0.85%. This means that for every dollar of RXO Inc's market capitalization, the company generates -0.85 cents in free cash flow.

What is the current Forward P/E ratio for RXO Inc (RXO) as of Mar 03 2026?

As of Mar 03 2026, RXO Inc (RXO) has a Forward P/E ratio of 414.19. This means the market is willing to pay $414.19 for every dollar of RXO Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for RXO Inc (RXO) as of Mar 03 2026?

As of Mar 03 2026, RXO Inc (RXO) has a Forward P/S ratio of 0.36. This means the market is valuing RXO at $0.36 for every dollar of expected revenue over the next 12 months.

RXO Valuation